YAP1 and neoplasm: At the same time, HIF can also be activated by PI3K/AKT (Yeh et al., 2018), YAP/TAZ (Simula et al., 2022), hippo/YAP1 (Sun et al., 2020) and other signaling pathways to further promote the glycolytic process of tumor cells.